Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis

被引:233
作者
Crotti, T
Smith, MD
Hirsch, R
Soukoulis, S
Weedon, H
Capone, M
Ahern, MJ
Haynes, D
机构
[1] Univ Adelaide, Dept Pathol, Adelaide, SA, Australia
[2] Flinders Med Ctr, Dept Med, Adelaide, SA, Australia
[3] Univ Adelaide, Sch Dent, Adelaide, SA, Australia
[4] Repatriat Gen Hosp, Rheumatol Res Unit, Adelaide, SA, Australia
[5] Flinders Univ S Australia, Dept Med, Adelaide, SA 5001, Australia
关键词
bone; periodontitis; receptor activator of nuclear factor kappa B ligand; osteoprotegerin; immunohistochemistry; T lymphocytes;
D O I
10.1034/j.1600-0765.2003.00615.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives and background: This study investigated the expression of key mediators that regulate differentiation of osteoclasts, receptor activator of nuclear factor KB ligand (RANKL), and its natural inhibitor, osteoprotegerin (OPG), in periodonitis. We aimed to compare the levels of the RANKL and OPG in the granulomatous tissue adjacent to areas of alveolar bone loss from patients with periodontitis to that present in tissue from patients without periodontitis. In addition, we aimed to determine the types of cells expressing these factors in these tissues and to demonstrate the expression of the osteoclastic markers, RANK and tartrate-resistant acid phosphatase (TRAP), in periodontitis. Materials and methods: Frozen biopsy specimens were analysed using specific monoclonal antibodies and were evaluated by semiquantitative analysis and digital image analysis to compare levels of RANKL and OPG protein expression. Double labelling of frozen sections with antibodies to different cell lineage specific markers was used to determine the types of cells expressing these proteins. In situ hybridization was used to detect cells expressing RANK mRNA. Results: Semiquantitative image analysis demonstrated that significantly higher levels of RANKL protein (P < 0.05) were expressed in the periodontitis tissue. Conversely, OPG protein was significantly lower (P < 0.05) in the periodontitis tissues. RANKL protein was associated with lymphocytes and macrophages. OPG protein was associated with endothelial cells in both tissues. Many leukocytes expressing RANK mRNA and TRAP were observed in periodontitis tissues. Conclusion: The change in the levels of these key regulators of osteoclast differentiation may play a major role in the bone loss seen in periodontitis.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 42 条
  • [1] Assuma R, 1998, J IMMUNOL, V160, P403
  • [2] Cytokine gene expression in chronic periodontitis
    Bickel, M
    Axtelius, B
    Solioz, C
    Attström, R
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (09) : 840 - 847
  • [3] Tumor necrosis factor-α and -β upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells
    Brändström, H
    Jonsson, KB
    Vidal, O
    Ljunghall, S
    Ohlsson, C
    Ljunggren, Ö
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) : 454 - 457
  • [4] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [5] The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
    Burgess, TL
    Qian, YX
    Kaufman, S
    Ring, BD
    Van, G
    Capparelli, C
    Kelley, M
    Hsu, HL
    Boyle, WJ
    Dunstan, CR
    Hu, S
    Lacey, DL
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 145 (03) : 527 - 538
  • [6] Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis
    Fujikawa, Y
    Sabokbar, A
    Neale, S
    Athanasou, NA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) : 816 - 822
  • [7] Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies normal controls
    Haynes, DR
    Barg, E
    Crotti, TN
    Holding, C
    Weedon, H
    Atkins, GJ
    Zannetino, A
    Ahern, MJ
    Coleman, M
    Roberts-Thomson, PJ
    Kraan, M
    Tak, PP
    Smith, MD
    [J]. RHEUMATOLOGY, 2003, 42 (01) : 123 - 134
  • [8] Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
    Haynes, DR
    Crotti, TN
    Loric, M
    Bain, GI
    Atkins, GJ
    Findlay, DM
    [J]. RHEUMATOLOGY, 2001, 40 (06) : 623 - 630
  • [9] The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis
    Haynes, DR
    Crotti, TN
    Potter, AE
    Loric, M
    Atkins, GJ
    Howie, DW
    Findlay, DM
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2001, 83B (06): : 902 - 911
  • [10] Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation
    Haynes, DR
    Atkins, GJ
    Loric, M
    Crotti, TN
    Geary, SM
    Findlay, DM
    [J]. BONE, 1999, 25 (03) : 269 - 278